No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
219 |
4. Check minimum number of eventsNone |
219 |
5. Include endpointsNone |
219 |
6. Filter based on genotype QC (FinnGen only) |
219 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF7
Similar endpoints
↥List of similar endpoints to
Complex cardiac defects
based on the number of shared cases.
Similar with more cases:
- Congenital malformations of heart and great arteries
- Congenital malformations, deformations and chromosomal abnormalities
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2105 | 1054 | 1036 |
| Only index persons | 1452 | 753 | 699 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.03 | 0.03 | 0.03 |
| Only index persons | 0.03 | 0.03 | 0.03 |
| Median age at first event (years) | |||
| Whole population | 5.92 | 8.36 | 2.74 |
| Only index persons | 11.17 | 16.28 | 5.66 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 219 | 127 | 92 |
| Unadjusted period prevalence (%) | 0.04 | 0.04 | 0.04 |
| Median age at first event (years) | 15.13 | 20.14 | 8.21 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 197
- Matched controls
- 1969
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
201
Kela drug reimbursment
Chronic cardiac insufficiency
110.7
96.0
100
18
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
27.3
79.2
120
106
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
59.8
72.6
84
24
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
39.9
72.6
93
43
B01AA03
ATC
warfarin; systemic
23.4
63.3
97
78
XF404
NOMESCO Finland
Ambulatory ECG
26.2
61.8
90
61
C03CA01
ATC
furosemide; systemic
17.1
60.2
109
133
C03DA01
ATC
spironolactone; oral
22.4
56.6
87
67
C01AA05
ATC
digoxin; systemic
51.2
51.4
61
17
Q20.48
ICD-10 Finland
Single ventricle
+∞
51.3
47
*
XF402
NOMESCO Finland
ECG with work load test
25.1
51.0
74
46
Q22.5
ICD-10 Finland
Ebstein anomaly
+∞
49.0
45
*
FM1DG
NOMESCO Finland
Very extensive MRI examination of heart with high intesity magnet
113.7
48.6
51
6
XF400
NOMESCO Finland
ECG with 12 standard connections
10.3
45.5
111
219
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
10.5
45.3
108
204
ZXE20
NOMESCO Finland
More than three and less than five hours
11.7
41.8
87
124
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
74.4
41.4
46
8
Q21.09
ICD-10 Finland
Ventricular septal defect NOS
88.2
38.7
42
6
Q21.00
ICD-10 Finland
Multiple ventricular septal defect
75.6
37.9
42
7
31
HP
Congenital heart failure surgery
+∞
37.7
35
*
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
27.5
36.3
50
24
Q20.3
ICD-10 Finland
Discordant ventriculoarterial connection
150.9
36.1
37
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
12.8
35.6
68
78
GD1AA
NOMESCO Finland
Thorax X-ray examination
6.7
33.9
131
450
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
11.9
33.4
66
80
Q21.08
ICD-10 Finland
Other specifed ventricular septal defect
37.7
33.3
42
14
TFC99
NOMESCO Finland
Catheterisation of heart with other procedure
58.4
32.9
38
8
61
HP
Catheterization and pressure measurement of the left side of the heart
84.5
32.1
35
5
Z2221
NOMESCO Finland
Medical doctor
6.3
31.6
121
398
ZXD10
NOMESCO Finland
Scheduled procedure
6.1
30.9
135
517
62
HP
Catheterization and pressure measurement of the right side of the heart
353.7
30.7
30
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
7.9
29.2
76
145
XF622
NOMESCO Finland
Measurement of minute volume of heart
112.7
27.5
29
*
TPH07
NOMESCO Finland
Cathetrisation of artery
8.3
27.3
67
115
ZXE10
NOMESCO Finland
More than one and less than three hours
5.1
25.7
119
450
FM2CE
NOMESCO Finland
NA
10.9
24.5
49
58
G04BE03
ATC
sildenafil; oral
77.7
24.5
27
*
Q20.5
ICD-10 Finland
Discordant atrioventricular connection
+∞
23.4
22
*
C01BD01
ATC
amiodarone; systemic
46.2
23.4
28
7
I36.1
ICD-10 Finland
Nonrheumatic tricuspid (valve) insufficiency
135.9
23.1
24
*
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
16.6
22.9
37
27
Q21.80
ICD-10 Finland
Communication from left ventricle to right atrium
+∞
22.3
21
*
ZXE30
NOMESCO Finland
More than five and less than seven hours
10.5
22.2
45
54
WX408
NOMESCO Finland
General anesthesy, balanced
4.6
21.4
105
394
Q20.40
ICD-10 Finland
Double inlet left ventricle
+∞
21.2
20
*
GAE10
NOMESCO Finland
Closure of previous incision of chest wall
47.4
21.0
25
6
I48
ICD-10 Finland
Atrial fibrillation and flutter
7.9
21.0
51
83
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
17.0
20.8
33
23
R4110
NOMESCO Finland
Physiotherapy
4.4
19.7
96
353
WX872
NOMESCO Finland
Intensive care
18.4
19.5
30
19
Q20.8
ICD-10 Finland
Other congenital malformations of cardiac chambers and connections
+∞
19.1
18
*
XF620
NOMESCO Finland
Examination of circulation with color method
110.7
18.9
20
*
Q20.1
ICD-10 Finland
Double outlet right ventricle
209.1
18.9
19
*
FDF05
NOMESCO Finland
Percutaneous transluminal occlusion of aorto-pulmonary collaterals
209.1
18.9
19
*
Z45.0
ICD-10 Finland
Adjustment and management of cardiac devices
17.7
18.7
29
19
Q21.10
ICD-10 Finland
Persistent ostium secundum
13.0
18.6
33
30
TFP20
NOMESCO Finland
Cardiodefibrillation
13.0
18.6
33
30
Q25.1
ICD-10 Finland
Coarctation of aorta
25.8
18.3
25
11
Q21.21
ICD-10 Finland
Atrioventricular duct
+∞
18.0
17
*
207
Kela drug reimbursment
Chronic arrhythmias
8.7
18.0
40
56
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
7.4
17.5
44
74
ZXE00
NOMESCO Finland
One hour or less
3.8
17.5
121
585
Q22.1
ICD-10 Finland
Congenital pulmonary valve stenosis
55.3
17.3
20
*
FAE00
NOMESCO Finland
Anastomosis to pulmonary artery from superior vena cava
+∞
16.9
16
*
7AX01
NOMESCO Finland
NA
98.6
16.9
18
*
XF600
NOMESCO Finland
Bloodpressure measurement
5.9
16.3
49
105
ZXE40
NOMESCO Finland
More than seven and less than nine hours
17.7
16.2
25
16
ZXD05
NOMESCO Finland
Urgent procedure
3.7
16.0
94
390
Q22.41
ICD-10 Finland
Tricuspid atresia
+∞
15.8
15
*
Q22.0
ICD-10 Finland
Pulmonary valve atresia
+∞
15.8
15
*
FXA10
NOMESCO Finland
Total cardiopulmonary bypass in deep hypothermia at concurrent surgical procedure
61.6
15.0
17
*
WX892
NOMESCO Finland
Monitored bed care
6.5
15.0
41
77
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
7.5
14.9
36
57
74639
ICD-8 Finland
Congenital anomalies of heart, Defectus septi ventriculorum
86.7
14.8
16
*
C07AB02
ATC
metoprolol; systemic
5.8
14.7
44
93
FAE10
NOMESCO Finland
Bidirectional anastomosis between superior vena cava and pulmonary artery
161.5
14.7
15
*
FN1BB
NOMESCO Finland
Contrast angiography of heart and/or coronary arteries after bypass surgery
29.8
14.6
19
7
XFE00
NOMESCO Finland
Epicardial ultrasonography
19.4
14.2
21
12
C07AA07
ATC
sotalol; systemic
22.1
14.1
20
10
Q23.4
ICD-10 Finland
Hypoplastic left heart syndrome
57.7
14.0
16
*
I50.9
ICD-10 Finland
Heart failure, unspecified
8.4
13.9
31
43
C09AA02
ATC
enalapril; systemic
5.3
13.8
45
105
Q25.21
ICD-10 Finland
Interrupted aortic arch
+∞
13.7
13
*
I44.2
ICD-10 Finland
Atrioventricular block, complete
28.1
13.6
18
7
FM1CG
NOMESCO Finland
Extensive examination of hear with high intensity magnet
149.9
13.6
14
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.5
13.6
83
343
Z3231
NOMESCO Finland
Registered nurse
3.2
13.1
97
460
Z98.8
ICD-10 Finland
Other specified postsurgical states
14.5
12.8
21
16
FPF20
NOMESCO Finland
Implantation of epicardial pacemaker with atrial and ventricular electrodes
74.8
12.8
14
*
7454A
ICD-9 Finland
Bulbus cordis anomalies and anomalies of cardiac septal closure, Ventricular septal defect[DEFECTUS SEPTI VENTRICULORUM NUD]
+∞
12.6
12
*
5255
FHL
Deep hypothermia (<20 °) with cardiopulmonary resuscitation
+∞
12.6
12
*
FBE10
NOMESCO Finland
Expansion or reconstruction of pulmonary artery using patch
+∞
12.6
12
*
Z94.1
ICD-10 Finland
Heart transplant status
138.5
12.6
13
*
C07AB07
ATC
bisoprolol; oral
3.4
12.5
75
300
ZX120
NOMESCO Finland
Intravenous
5.4
12.5
39
86
FPE30
NOMESCO Finland
Replacement of transvenous cardiac pacemaker pulse generator
28.8
12.3
16
6
FN1CC
NOMESCO Finland
Very extensive angiography of heart and/or coronary arteries
49.9
12.0
14
*
ZX108
NOMESCO Finland
Inhalation
20.5
11.8
17
9
I35.1
ICD-10 Finland
Aortic (valve) insufficiency
12.9
11.6
20
17
Q25.0
ICD-10 Finland
Patent ductus arteriosus
12.9
11.6
20
17
Q24.0
ICD-10 Finland
Dextrocardia
127.1
11.6
12
*
FDA00
NOMESCO Finland
Aortoplasty and aorto-pulmonary shunt for HLHS
127.1
11.6
12
*
I47.1
ICD-10 Finland
Supraventricular tachycardia
9.0
11.5
24
30
XF640
NOMESCO Finland
NA
13.0
11.1
19
16
Q21.19
ICD-10 Finland
Atrial septal defect NOS
46.1
11.1
13
*
ZX199
NOMESCO Finland
Other rote
19.2
10.9
16
9
TFB00
NOMESCO Finland
Cathetrisation of pulmonal artery
63.5
10.7
12
*
Z3226
NOMESCO Finland
Physiotherapist
3.2
10.7
68
282
Q24.4
ICD-10 Finland
Congenital subaortic stenosis
115.9
10.5
11
*
Q20.9
ICD-10 Finland
Congenital malformation of cardiac chambers and connections, unspecified
+∞
10.5
10
*
TFJ02
NOMESCO Finland
Muscle biopsy of heart
+∞
10.5
10
*
ZSF00
NOMESCO Finland
Procedure related to previous procedure classified in chapter F
+∞
10.5
10
*
7455A
ICD-9 Finland
Bulbus cordis anomalies and anomalies of cardiac septal closure, Ostium secundum type atrial septal defect
+∞
10.5
10
*
WX882
NOMESCO Finland
High dependency care
4.5
10.4
38
99
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
3.4
9.8
53
194
FFC22
NOMESCO Finland
Percutaneous transluminal closure of ostium secundum type ASD
18.7
9.5
14
8
74619
ICD-8 Finland
Congenital anomalies of heart, Transposition of great vessels
104.9
9.5
10
*
7471A
ICD-9 Finland
Other congenital anomalies of circulatory system, Coarctation of aorta[COARCTATIO AORTAE]
104.9
9.5
10
*
Q21.18
ICD-10 Finland
Other spedified atrial septal defect
104.9
9.5
10
*
Z95.2
ICD-10 Finland
Presence of prosthetic heart valve
23.0
9.5
13
6
WX704
NOMESCO Finland
Intubation
4.9
9.5
31
72
Q20.60
ICD-10 Finland
Left isomerism of atrial appendages
+∞
9.4
9
*
7451A
ICD-9 Finland
Bulbus cordis anomalies and anomalies of cardiac septal closure, Transposition of great vessels[TRANSPOSITIO CORDIS COMPLETA]
+∞
9.4
9
*
7453B
ICD-9 Finland
Bulbus cordis anomalies and anomalies of cardiac septal closure, Common ventricle[COMMON VENTRICLE]
+∞
9.4
9
*
FGC10
NOMESCO Finland
Annuloplasty of tricuspid valve using prosthetic ring
+∞
9.4
9
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.2
9.3
54
206
WZC30
NOMESCO Finland
Teaching
4.2
9.3
36
99
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
11.5
9.0
16
15
I50.1
ICD-10 Finland
Left ventricular failure
11.5
9.0
16
15
Z2446
NOMESCO Finland
Social worker
3.4
8.7
44
152
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
17.3
8.7
13
8
FXA20
NOMESCO Finland
Total cardiopulmonary bypass in deep hypothermia and circulatory arrest at concurrent surgical procedure
93.9
8.5
9
*
K83
ICPC
Heart valve disease NOS
93.9
8.5
9
*
Q24.3
ICD-10 Finland
Pulmonary infundibular stenosis
93.9
8.5
9
*
Q21.9
ICD-10 Finland
Congenital malformation of cardiac septum, unspecified
93.9
8.5
9
*
FN1CD
NOMESCO Finland
Very extensive CT of coronary arteries
93.9
8.5
9
*
RS224
NOMESCO Finland
NA
11.5
8.5
15
14
602
Kela drug reimbursment
Children's severe malnutrition
7.1
8.4
20
31
74663
ICD-8 Finland
Congenital anomalies of heart, Stenosis valvulae pulmonalis
+∞
8.4
8
*
Q21.88
ICD-10 Finland
Other congenital malformations of cardiac septa
+∞
8.4
8
*
FQA00
NOMESCO Finland
Orthotopic transplantation of heart
+∞
8.4
8
*
7454C
ICD-9 Finland
Bulbus cordis anomalies and anomalies of cardiac septal closure, Ventricular septal defect[LEFT VENTRICULAR AND RIGHT ATRIAL COMMUNICATION]
+∞
8.4
8
*
74689
ICD-8 Finland
Congenital anomalies of heart, Aliae definitae
+∞
8.4
8
*
Q22.40
ICD-10 Finland
Congenital tricuspid stenosis
+∞
8.4
8
*
FGB10
NOMESCO Finland
Repair of Ebstein's anomaly with mobilisation and ventricular plication
+∞
8.4
8
*
Q20.00
ICD-10 Finland
Common arterial trunk
+∞
8.4
8
*
Q24.8
ICD-10 Finland
Other specified congenital malformations of heart
+∞
8.4
8
*
I50.0
ICD-10 Finland
Congestive heart failure
9.6
8.2
16
18
J18.9
ICD-10 Finland
Pneumonia, unspecified
3.1
8.1
49
192
Q23.11
ICD-10 Finland
Bicuspid aortic valve
15.9
7.8
12
8
B01AB05
ATC
enoxaparin; parenteral
2.9
7.8
53
223
FM1BD
NOMESCO Finland
Extensive CT of heart
46.9
7.8
9
*
I49.5
ICD-10 Finland
Sick sinus syndrome
10.7
7.7
14
14
TPH04
NOMESCO Finland
Cathetrisation of vein
2.8
7.6
54
233
AP2
HP
Catheterization of the right side of the heart
83.1
7.5
8
*
FBJ10
NOMESCO Finland
Anastomosis to pulmonary artery from subclavian artery with interposition graft
83.1
7.5
8
*
I48.0
ICD-10 Finland
Paroxysmal atrial fibrillation
8.9
7.5
15
18
Q21.8
ICD-10 Finland
Other congenital malformations of cardiac septa
+∞
7.3
7
*
5253
FHL
Cardiac lung machine
+∞
7.3
7
*
FLE96
NOMESCO Finland
Other repair of outlet obstruction of left ventricle
+∞
7.3
7
*
FFK20
NOMESCO Finland
Atrio-pulmonary anastomosis
+∞
7.3
7
*
Q20.41
ICD-10 Finland
Double inlet right ventricle
+∞
7.3
7
*
7459X
ICD-9 Finland
Bulbus cordis anomalies and anomalies of cardiac septal closure, Unspecified defect of septal closure
+∞
7.3
7
*
AF1
HP
Surgery of congenital heart defect
+∞
7.3
7
*
7461A
ICD-9 Finland
Other congenital anomalies of heart, Tricuspid atresia and stenosis, congenital[VITIUM VALVULAE TRICUSPIDALIS CONGENITUM CUM ATRESI]
+∞
7.3
7
*
R06.0
ICD-10 Finland
Dyspnoea
2.9
7.3
47
190
Q21.0
ICD-10 Finland
Ventricular septal defect
31.3
7.2
9
*
I47.2
ICD-10 Finland
Ventricular tachycardia
31.3
7.2
9
*
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
5.9
7.1
19
35
Q25.40
ICD-10 Finland
Aortic hypoplasia
41.5
6.8
8
*
I34.09
ICD-10 Finland
Mitral (valve) insufficiency
8.3
6.7
14
18
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
3.7
6.5
28
85
Q21.11
ICD-10 Finland
Paten or persistent foramen ovale
7.0
6.5
15
23
7454B
ICD-9 Finland
Bulbus cordis anomalies and anomalies of cardiac septal closure, Ventricular septal defect[DEFECTUS SEPTI VENTRICULORUM SIMPLEX]
72.1
6.5
7
*
FAE30
NOMESCO Finland
Total cavo-pulmonary connection using fenestrated patch
72.1
6.5
7
*
FBE35
NOMESCO Finland
Percutaneous transluminal angioplasty of pulmonary artery with insertion of stent
72.1
6.5
7
*
Q24.9
ICD-10 Finland
Congenital malformation of heart, unspecified
72.1
6.5
7
*
FXA13
NOMESCO Finland
Total cardiopulmonary bypass in deep hypothermia and exclusive cerebral perfusion
72.1
6.5
7
*
74642
ICD-8 Finland
Congenital anomalies of heart, Defectus septi atriorum, ostium secundum
72.1
6.5
7
*
Z01.8
ICD-10 Finland
Other specified special examinations
2.6
6.5
51
233
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
8.6
6.4
13
16
FPE20
NOMESCO Finland
Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes
9.7
6.4
12
13
Q25.41
ICD-10 Finland
Persistent right-sided aortic arch
+∞
6.3
6
*
7462A
ICD-9 Finland
Other congenital anomalies of heart, Ebstein's anomaly[ANOMALIA EBSTEIN]
+∞
6.3
6
*
AP3
HP
Catheterization of the right and left side of the heart
+∞
6.3
6
*
FPH00
NOMESCO Finland
Transvenous extraction of transvenous cardiac pacemaker or cardioverter-defibrillator
+∞
6.3
6
*
Q22.6
ICD-10 Finland
Hypoplastic right heart syndrome
+∞
6.3
6
*
7451B
ICD-9 Finland
Bulbus cordis anomalies and anomalies of cardiac septal closure, Transposition of great vessels[DOUBLE OUTLET RIGHT VENTRICLE]
+∞
6.3
6
*
Q20.4
ICD-10 Finland
Double inlet ventricle
+∞
6.3
6
*
Q21.15
ICD-10 Finland
Common atrium
+∞
6.3
6
*
7456C
ICD-9 Finland
Bulbus cordis anomalies and anomalies of cardiac septal closure, Endocardial cushion defects[ASD CANALIS ATRIOVENTRICULARIS COMMUNIS]
+∞
6.3
6
*
5409
FHL
Other measure in this category
+∞
6.3
6
*
4273A
ICD-9 Finland
Cardiac dysrhythmias, Atrial fibrillation and flutter
+∞
6.3
6
*
5233
FHL
Right ventricular bypass surgery (Fontan et al.)
+∞
6.3
6
*
FEB10
NOMESCO Finland
Decompression and drainage of pericardium
27.6
6.3
8
*
81
HP
Angiography of the heart and coronary arteries
8.1
6.2
13
17
127
Kela drug reimbursment
Transplant complication
8.1
6.2
13
17
WX402
NOMESCO Finland
General anaesthesia
2.5
6.1
54
262
C02EA02
ATC
NA
10.5
6.1
11
11
3820A
ICD-9 Finland
Suppurative and unspecified otitis media, Acute suppurative otitis media
7.6
6.0
13
18
WZB00
NOMESCO Finland
Telephone receipt or other advice
2.3
6.0
68
372
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
165
259
22.78
120.78
11.1
3.7
ng/l
760.1
799.0
0.11
160
216
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
56
32
23.17
71.27
3.9
6.0
%
72.6
98.8
4.98
56
32
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
104
220
8.10
52.66
7.0
3.0
ng/l
2944.2
519.8
1.24
89
131
(3032080) INR in Blood by Coagulation assay
148
456
7.93
51.05
19.9
6.5
inr
1.8
1.1
4.68
28
147
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
45
38
14.65
46.03
25.6
8.2
u/ml
0.3
0.3
0.21
32
22
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
66
97
9.31
45.67
5.1
8.0
%
181.2
163.1
0.85
66
97
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
85
207
6.08
35.59
3.8
2.7
%
19.7
23.6
1.85
76
189
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
108
379
4.65
28.18
4.2
2.9
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
54
107
6.37
27.56
39.8
12.8
inr
2.1
1.2
—
8
17
(3014576) Chloride [Moles/volume] in Serum or Plasma
66
162
5.40
26.65
14.6
11.3
mmol/l
106.4
104.7
1.96
66
157
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
39
60
7.69
25.21
37.6
19.7
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
38
59
7.58
24.33
40.6
12.5
mmol/l
24.5
24.5
0.02
38
59
(3044640) Blood type and Crossmatch panel - Blood
119
490
4.13
24.13
4.3
3.0
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
97
357
4.08
22.85
6.3
3.5
mg/l
1.8
1.0
1.57
77
270
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
27
35
8.66
20.01
1.4
1.7
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
26
33
8.81
19.58
6.5
26.2
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
123
612
3.30
16.99
11.6
7.4
g/l
37.4
37.3
0.10
118
575
(3003396) Base excess in Arterial blood by calculation
48
129
4.48
16.84
33.4
12.5
mmol/l
0.9
1.2
0.27
43
105
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
36
77
5.40
16.56
42.9
10.9
%
1.1
1.3
1.36
36
77
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
36
77
5.40
16.56
42.9
10.9
%
0.7
0.7
0.11
36
77
(3019230) Fractional oxyhemoglobin in Venous blood
23
32
7.91
16.00
7.2
23.1
%
73.3
72.3
0.08
23
32
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
133
720
3.16
15.42
5.4
4.5
—
—
—
0
0
(3044889) 12 lead EKG panel
158
955
3.35
14.93
6.6
3.0
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
58
197
3.64
14.57
2.7
2.1
—
—
—
0
0
(3000991) Gas panel - Venous blood
67
257
3.32
13.85
30.2
10.3
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
90
420
2.94
13.14
5.1
3.4
ng/l
60.3
18.7
1.25
54
215
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
12
10
12.64
11.83
1.4
1.2
%
164.4
122.6
—
12
10
(3002032) Base excess in Venous blood by calculation
66
273
3.03
11.81
9.2
10.5
mmol/l
1.0
1.2
0.19
54
213
(42870588) Differential panel, method unspecified - Blood
122
702
2.67
11.47
9.6
9.6
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
13
13
10.57
11.45
5.2
2.7
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
150
960
2.79
11.31
18.3
6.9
mmol/l
6.1
6.3
0.77
145
884
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
12
11
11.48
11.15
3.5
12.4
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
12
11
11.48
11.15
3.5
12.4
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
85
417
2.70
10.92
4.1
3.3
mg/l
3.8
2.8
0.85
79
364
(3023368) Bacteria identified in Blood by Culture
73
333
2.79
10.80
7.0
4.9
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
64
273
2.90
10.72
27.8
13.8
mmol/l
24.9
25.1
0.30
64
273
(3007853) Bacteria identified in Skin by Aerobe culture
53
206
3.07
10.46
2.5
1.7
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
19
34
6.02
10.42
1.2
1.1
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
13
15
9.15
10.33
1.4
1.3
%
126.1
134.6
0.15
13
15
(4306422)
17
28
6.50
10.08
1.2
1.2
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
19
37
5.53
9.55
1.3
1.2
u/ml
1.3
1.4
—
6
18
(3011648) Oxygen content in Venous blood
15
23
6.93
9.48
9.5
31.0
%
11.3
12.1
0.45
15
23
(3018738) Hemoglobin F/Hemoglobin.total in Blood
13
17
8.07
9.37
4.8
3.4
%
1.2
2.4
—
5
9
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
128
808
2.41
9.16
20.6
11.3
mmol/l
1.2
1.2
2.53
119
722
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
15
24
6.64
9.12
1.1
1.3
%
79.0
94.9
0.90
15
24
(40758558) Short blood count panel - Blood
98
555
2.39
8.92
8.4
9.6
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
26
71
4.02
8.74
7.6
13.3
%
0.7
0.7
0.25
26
71
(3022313) Gas panel - Capillary blood
53
226
2.77
8.73
17.4
8.5
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
127
817
2.32
8.46
4.5
3.1
ug/l
97.5
79.8
0.51
121
763
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
56
254
2.62
8.13
17.3
9.1
mmol/l
1.1
1.2
0.10
43
190
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
11
5
23.04
8.10
3.6
1.8
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
18
39
4.94
8.03
1.2
1.2
u/ml
5.0
2.8
—
10
20
(3000494) Fungus identified in Specimen by Culture
41
159
2.94
8.00
2.0
1.6
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
14
24
6.16
7.96
4.4
2.5
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
56
258
2.57
7.86
17.6
9.0
kpa
5.0
5.0
0.15
56
242
(3024932) HLA-DR beta [Type]
12
18
7.00
7.69
1.0
1.2
—
—
—
0
0
(3024471) HLA-A [Type]
12
18
7.00
7.69
1.0
1.0
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
13
23
5.95
7.15
4.1
2.3
—
—
—
0
0
(4268621)
14
27
5.47
7.07
2.4
2.2
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
19
50
4.07
6.69
4.4
2.8
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
66
352
2.25
6.58
4.2
2.3
u/l
430.7
166.5
1.60
66
342
(3028626) Oxygen [Partial pressure] in Capillary blood
47
218
2.47
6.41
18.2
8.6
kpa
8.7
9.7
2.07
47
206
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
16
40
4.24
6.01
3.0
2.6
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
138
1001
2.02
5.84
10.3
8.7
e9/l
0.6
0.6
0.73
128
848
(3006315) Basophils [#/volume] in Blood
138
1005
2.01
5.73
10.3
8.6
e9/l
0.0
0.0
0.08
128
850
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
39
177
2.46
5.54
2.1
1.8
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
140
1036
1.97
5.42
11.5
9.5
e9/l
0.2
0.2
1.24
131
898
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
38
174
2.43
5.29
2.3
1.9
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
14
36
4.09
5.07
1.5
3.6
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
14
36
4.09
5.07
1.6
1.3
—
—
—
0
0
(3018418) pH of Serum or Plasma
70
418
1.99
5.03
5.4
3.9
ph
7.4
7.4
1.73
14
76
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
165
1313
2.04
4.94
20.7
9.3
ml/min/173m2
96.0
94.5
0.30
138
1005
(3002582) Erythrocytes [#/volume] in Urine
82
523
1.91
4.83
4.0
3.8
e6/l
29.7
39.7
0.24
62
403
(3015377) Calcium [Moles/volume] in Serum or Plasma
78
490
1.92
4.80
3.9
3.1
mmol/l
2.4
2.4
0.48
72
443
(3019198) Lymphocytes [#/volume] in Blood
138
1040
1.88
4.79
10.3
8.6
e9/l
1.7
2.1
6.75
128
901
(3034426) Prothrombin time (PT)
9
11
8.47
4.60
1.0
1.2
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
52
287
2.06
4.60
2.7
3.8
e6/l
2.7
2.5
0.06
28
170
(3021589) Normoblasts [#/volume] in Blood
128
954
1.82
4.48
13.2
11.3
e9/l
0.0
0.0
0.44
108
734
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
9
12
7.77
4.40
1.2
1.5
umol/l
13.7
10.3
—
9
12
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
18
61
3.13
4.40
13.6
8.4
iu/ml
1792.6
546.2
—
5
9
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
18
61
3.13
4.40
1.8
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
18
61
3.13
4.40
1.8
1.3
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
44
232
2.12
4.38
2.4
2.0
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
75
478
1.87
4.35
4.1
3.8
e6/l
0.4
0.2
0.62
55
364
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
12
31
4.04
4.32
2.0
2.7
ug/l
2.0
2.2
0.05
12
26
(3012441) Differential panel - Pleural fluid
7
6
11.99
4.30
2.0
1.2
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
91
618
1.81
4.29
4.8
4.6
e6/l
9.8
49.9
2.39
63
424
(36304419) Bacteria [Presence] in Urine
75
483
1.84
4.19
4.0
3.8
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
32
153
2.28
4.03
6.2
4.5
e9/l
69.6
66.0
0.14
19
105
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
86
584
1.78
4.00
4.3
4.1
—
—
—
0
0
(3026782) Osmolality of Urine
56
333
1.92
3.98
3.9
3.1
mosm/kgh2o
622.6
578.8
0.70
51
284
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
8
11
7.50
3.89
2.5
1.1
%
57.6
107.3
—
8
11
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
17
60
2.99
3.89
2.1
2.1
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
6
5
12.28
3.78
1.8
1.4
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
9
16
5.81
3.70
1.3
1.3
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
12
35
3.57
3.67
1.5
2.0
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
15
51
3.08
3.65
6.1
7.4
mmol/l
21.8
24.1
3.06
15
43
(3002385) Erythrocyte distribution width [Ratio]
192
1679
2.16
3.57
36.5
16.3
%
13.9
13.4
3.96
192
1651
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
9
17
5.47
3.55
1.7
1.2
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
15
52
3.02
3.54
8.7
8.8
—
3936.5
—
0
6
(1761868) Lipid panel - Serum or Plasma
32
566
0.49
3.48
2.5
2.3
—
—
—
0
0
(3013512) EKG study
50
301
1.86
3.39
7.4
3.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
48
288
1.85
3.28
2.7
3.7
e6/l
0.5
0.8
0.88
24
171
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
6
7
8.77
3.28
1.8
2.4
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
205
1856
2.64
3.26
22.3
10.3
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
14
49
2.98
3.25
1.9
2.0
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
82
577
1.67
3.22
1.6
1.6
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
7
11
6.53
3.21
1.3
1.2
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
200
1794
2.32
3.20
26.5
12.3
mg/l
24.7
21.1
0.94
166
1298
(3013650) Neutrophils [#/volume] in Blood by Automated count
140
1132
1.66
3.15
12.9
11.8
e9/l
3.8
3.8
0.01
129
968
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
21
93
2.39
3.15
2.2
3.0
ml/min/173m2
73.7
75.5
—
7
34
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
5
178
0.26
3.14
2.2
1.5
—
—
—
0
0
(44806118)
12
39
3.20
3.14
2.1
2.4
—
—
—
0
0
(44790047)
12
39
3.20
3.14
2.1
2.4
—
—
—
0
0
(44790049)
12
39
3.20
3.14
2.1
2.4
—
—
—
0
0
(44790048)
12
39
3.20
3.14
2.1
2.4
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
16
63
2.66
3.03
2.1
2.1
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
5
5
10.19
2.99
1.4
1.6
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
12
41
3.04
2.90
1.3
3.5
e9/l
0.9
1.7
—
7
25
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
20
91
2.32
2.83
1.6
1.7
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
5
171
0.28
2.83
1.8
1.8
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
140
1623
0.62
2.81
3.6
3.7
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
53
343
1.72
2.79
3.8
2.9
e6/l
3.6
5.1
1.18
48
307
(3024891) Influenza virus A+B Ag [Presence] in Specimen
20
93
2.27
2.70
1.5
1.2
—
—
—
0
0
(3019060) Gas panel - Arterial blood
16
67
2.50
2.70
3.7
11.6
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
199
1806
2.12
2.68
41.6
14.6
%
39.9
40.2
0.21
180
1539
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
11
39
2.92
2.51
1.3
3.3
e9/l
0.3
0.2
—
5
29
(3014148) Varicella zoster virus Ab [Titer] in Serum
13
51
2.65
2.49
1.3
1.2
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
11
40
2.84
2.41
1.6
1.9
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
5
8
6.36
2.38
1.2
1.5
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
7
17
4.22
2.38
4.6
5.7
—
—
—
0
0
(40768441) Liver Pathology biopsy report
7
17
4.22
2.38
1.1
2.0
—
—
—
0
0
(3002256) Pathology report gross observation
30
173
1.85
2.32
1.3
1.2
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
22
118
1.96
2.10
2.2
3.3
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
16
76
2.19
2.08
1.6
1.5
—
—
—
0
0
(4281824)
5
10
5.09
2.08
1.4
1.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
9
32
2.89
2.02
2.8
4.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
28
166
1.79
1.99
1.4
1.6
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
7
21
3.41
1.98
1.9
1.3
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
134
1137
1.46
1.97
5.2
4.4
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
0
52
0.00
1.91
0.0
1.1
—
2.0
—
0
24
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
20
108
1.94
1.89
1.9
1.8
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
10
40
2.57
1.86
1.2
1.5
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
10
40
2.57
1.86
1.3
3.3
e6/l
265.2
502.9
—
5
29
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
7
23
3.11
1.81
2.9
1.7
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
31
197
1.67
1.75
1.8
2.5
mmol/l
2.4
2.4
0.24
25
166
(3019309) Folate [Moles/volume] in Red Blood Cells
28
174
1.70
1.71
1.4
1.6
nmol/l
1045.0
1139.6
0.16
22
130
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
8
31
2.64
1.67
1.1
1.2
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
31
2.64
1.67
1.6
1.8
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
52
378
1.49
1.66
3.2
3.7
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
8
32
2.56
1.61
1.3
1.3
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
5
125
0.39
1.55
1.0
1.2
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
5
15
3.39
1.53
1.6
1.3
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
12
58
2.13
1.52
1.3
1.1
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
41
290
1.51
1.49
1.6
1.6
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
47
624
0.69
1.48
1.6
1.6
u/ml
0.4
1.8
—
5
127
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
9
177
0.49
1.48
1.1
1.1
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
17
95
1.86
1.48
3.2
1.7
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
6
22
2.77
1.44
1.3
1.9
—
—
—
0
0
(4035726)
20
119
1.75
1.43
3.7
1.6
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
14
75
1.93
1.38
1.2
1.4
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
6
24
2.54
1.31
1.5
1.9
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
6
24
2.54
1.31
5.5
4.6
umol/l
22.8
27.2
—
6
24
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
59
459
1.39
1.31
2.0
1.7
pmol/l
86.8
101.1
1.21
31
226
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
9
44
2.09
1.28
1.3
1.3
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
8
35
2.33
1.28
6.5
19.5
mmol/l
1.1
1.1
—
8
30
(3020393) Adenovirus Ag [Presence] in Stool
6
25
2.44
1.25
1.2
2.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
25
165
1.58
1.24
2.0
1.8
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
8
37
2.21
1.23
3.0
4.0
u/ml
20.9
15.7
—
8
37
(3021440) Promyelocytes/100 leukocytes in Blood
20
125
1.66
1.22
3.6
6.1
%
0.0
0.3
—
6
34
(3029634) Reagin Ab [Titer] in Serum by VDRL
8
38
2.15
1.19
1.8
1.7
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
6
26
2.34
1.19
1.0
1.0
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
33
450
0.69
1.18
3.4
3.0
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
55
431
1.37
1.16
3.2
2.8
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
5
111
0.44
1.16
1.4
1.6
mu/l
294.0
318.4
—
5
105
(3017181) Myelocytes/100 leukocytes in Blood
21
135
1.61
1.16
3.6
5.9
%
0.4
0.7
—
6
39
(3016650) Hepatitis A virus Ab [Presence] in Serum
7
30
2.38
1.13
1.1
1.0
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
7
32
2.23
1.09
1.9
4.8
e9/l
5.8
4.2
—
7
32
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
7
32
2.23
1.09
1.7
4.9
%
64.7
55.6
—
7
32
(3004588) Protein electrophoresis panel - Serum or Plasma
10
52
1.97
1.08
1.2
2.1
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
16
98
1.68
1.06
3.3
1.7
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
16
98
1.68
1.06
3.6
4.7
mmol/l
1.3
1.2
0.78
16
88
(3008037) Lactate [Moles/volume] in Venous blood
5
22
2.30
1.04
10.4
2.3
mmol/l
1.4
1.2
—
5
22
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
16
99
1.66
1.03
2.3
2.0
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
5
23
2.20
0.98
3.0
1.7
e6/l
16693.8
6343.8
—
5
16
(3038177) Helicobacter pylori Ab [Presence] in Serum
0
31
0.00
0.97
0.0
1.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
31
412
0.71
0.96
1.7
1.8
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
12
70
1.76
0.94
2.3
2.2
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
6
27
2.26
0.94
1.2
1.3
—
—
—
0
0
(1616796) Gas panel - Central venous blood
6
27
2.26
0.94
3.8
4.8
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
11
181
0.59
0.92
2.8
1.6
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
6
28
2.17
0.92
3.5
3.8
kpa
8.9
8.6
—
6
28
(3013290) Carbon dioxide [Partial pressure] in Blood
6
28
2.17
0.92
3.5
3.8
kpa
4.6
5.0
—
6
28
(3016879) Cocaine [Presence] in Urine
10
168
0.58
0.91
2.8
1.6
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
11
180
0.59
0.91
2.6
1.5
—
—
—
0
0
(3027901) Hemoglobin [Mass/volume] in Arterial cord blood
6
29
2.10
0.90
1.0
1.0
g/l
153.7
163.8
—
6
29
(3027944) Amphetamines [Presence] in Urine
11
178
0.60
0.87
2.7
1.6
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
11
178
0.60
0.87
2.6
1.6
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
63
525
1.28
0.87
1.7
2.1
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
49
598
0.77
0.87
3.9
3.4
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
8
46
1.77
0.83
1.1
2.9
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
10
162
0.60
0.80
1.1
1.5
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
24
0.00
0.79
0.0
12.5
—
760.3
—
0
24
(3011897) Casein IgE Ab [Units/volume] in Serum
0
27
0.00
0.78
0.0
1.5
—
3.3
—
0
6
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
27
0.00
0.78
0.0
1.1
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
6
34
1.79
0.77
2.3
1.8
—
—
—
0
0
(3010421) pH of Blood
6
34
1.79
0.77
3.5
3.5
ph
7.4
7.4
—
6
28
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
50
411
1.28
0.77
1.6
1.7
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
0
28
0.00
0.76
0.0
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
0
28
0.00
0.76
0.0
1.1
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
10
60
1.70
0.73
1.6
1.6
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
16
227
0.68
0.73
1.1
1.3
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
20
272
0.71
0.72
1.3
1.2
u/ml
4.8
7.9
—
6
119
(1001926) Buprenorphine [Presence] in Urine by Screen method
9
142
0.62
0.72
3.0
1.6
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
7
118
0.58
0.70
4.7
1.9
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
124
1140
1.20
0.65
6.1
3.8
u/l
67.0
35.6
3.40
119
1084
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
31
384
0.78
0.62
1.4
2.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
18
131
1.41
0.61
10.1
5.3
—
—
—
0
0
(4027681)
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
0
21
0.00
0.60
0.0
8.2
—
38.4
—
0
5
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
113
0.61
0.60
1.1
1.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
13
183
0.69
0.58
1.3
1.9
—
—
—
0
0
(3020891) Body temperature
8
54
1.50
0.58
4.5
6.1
—
—
—
0
0
(4010399)
13
90
1.47
0.57
2.2
1.3
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
6
99
0.60
0.53
1.7
1.9
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
6
40
1.51
0.52
2.3
1.2
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
10
67
1.52
0.50
9.4
4.7
%
47.0
55.2
—
10
67
(3050129) First trimester maternal screen panel - Serum or Plasma
7
110
0.62
0.49
1.6
1.4
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
26
319
0.79
0.49
1.4
1.8
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
7
47
1.51
0.48
2.4
2.1
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
5
81
0.61
0.46
3.2
1.9
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
21
166
1.29
0.45
1.3
1.4
u/ml
55.4
355.9
1.38
21
155
(3000492) Spirometry study
21
167
1.28
0.43
1.4
1.4
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
10
70
1.45
0.42
1.6
1.2
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(4034850)
5
34
1.48
0.40
6.2
6.4
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
10
71
1.43
0.40
1.3
1.2
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
19
0.00
0.39
0.0
4.5
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
19
0.00
0.39
0.0
4.5
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
5
36
1.40
0.38
1.8
3.5
mmol/l
3.9
3.9
—
5
31
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
36
413
0.85
0.36
1.4
2.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
5
76
0.65
0.36
1.2
1.5
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
6
41
1.48
0.36
5.0
2.9
u/ml
77.0
3275.0
—
6
36
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
6
41
1.48
0.36
2.3
1.7
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
10
73
1.39
0.35
1.1
1.2
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
12
155
0.76
0.34
1.3
1.4
iu/ml
167.2
150.6
—
6
57
(36660697) Celiac disease serology panel - Serum
21
252
0.82
0.34
1.3
1.2
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
6
47
1.28
0.32
4.0
1.4
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
24
282
0.83
0.32
1.2
1.2
iu/ml
11.3
18.6
—
7
83
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
7
99
0.70
0.31
1.1
1.3
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
7
54
1.31
0.30
1.0
1.7
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
8
63
1.28
0.28
1.9
1.6
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
5
72
0.69
0.26
1.2
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
5
72
0.69
0.26
1.2
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
6
83
0.72
0.24
1.3
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
6
83
0.72
0.24
1.3
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
6
83
0.72
0.24
1.3
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
6
83
0.72
0.24
1.3
1.4
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
5
38
1.32
0.23
2.4
1.5
nmol/l
0.2
0.3
—
5
28
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
7
91
0.76
0.23
1.3
1.5
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
19
220
0.85
0.22
1.5
2.0
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
126
1305
0.92
0.22
4.4
4.2
mmol/mol
37.4
37.7
0.12
117
1234
(3003327) Ova and parasites identified in Stool by Light microscopy
8
101
0.78
0.21
1.8
1.6
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
1425.8
—
0
11
(3015183) Erythrocyte sedimentation rate
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
11
0.00
0.21
0.0
2.1
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
2.7
—
0
6
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
0
10
0.00
0.21
0.0
6.8
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
0
10
0.00
0.21
0.0
6.8
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
8.6
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
5
43
1.17
0.21
2.4
1.9
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
27.7
—
0.6
—
0
13
(3029075) Extractable nuclear Ab panel - Serum
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3008092) Baker's yeast IgG Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.3
—
21.4
—
0
5
(3013247) Albumin in CSF/Albumin in Serum or Plasma
0
13
0.00
0.21
0.0
1.0
—
7.2
—
0
13
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.0
—
0.9
—
0
6
(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.1
—
32.3
—
0
6
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
0
13
0.00
0.21
0.0
1.7
—
—
—
0
0
(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.1
—
1.7
—
0
6
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
14
0.00
0.20
0.0
4.8
—
86.5
—
0
14
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
14
0.00
0.20
0.0
5.9
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
8.6
—
0.6
—
0
14
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
14
0.00
0.20
0.0
2.9
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
6
52
1.16
0.19
1.2
1.5
—
0.0
—
0
12
(3003740) Influenza virus B Ag [Presence] in Specimen
7
62
1.13
0.17
1.3
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
7
63
1.11
0.17
1.0
1.2
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
7
63
1.11
0.17
1.3
1.1
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
5
66
0.75
0.17
1.4
1.6
—
232.0
—
0
5
(3037522) Nuclear Ab [Titer] in Serum
28
255
1.11
0.16
1.5
1.5
titre
265.0
439.1
—
8
46
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
13
112
1.17
0.14
1.2
1.3
—
34.2
—
0
7
(3022145) Colonoscopy Study observation
13
148
0.87
0.13
1.5
1.5
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
144
1466
0.95
0.11
3.9
3.5
mmol/l
1.3
1.5
3.27
138
1374
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
75
725
1.05
0.10
4.2
3.0
nmol/l
71.4
72.2
0.10
69
668
(3019225) pH of Specimen
11
96
1.15
0.10
9.1
5.5
—
—
—
0
0
(3008898) HLA-B27 [Presence]
13
116
1.13
0.09
1.1
1.0
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
11
97
1.14
0.09
1.0
1.2
—
—
—
0
0
(3006598) pH of Arterial cord blood
6
54
1.11
0.09
1.0
1.0
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
6
57
1.05
0.08
1.5
1.4
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
82
798
1.04
0.08
3.5
3.5
estimate
0.0
0.0
0.00
15
158
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
138
1400
0.96
0.07
4.0
3.3
mmol/l
1.3
1.2
0.10
131
1313
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
12
108
1.12
0.07
1.8
2.2
ug/l
0.3
0.7
—
7
47
(3015736) pH of Urine
62
639
0.96
0.07
3.5
3.3
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
7
83
0.84
0.07
1.3
1.6
—
—
—
0
0
(3022621) pH of Urine by Test strip
7
83
0.84
0.07
3.0
2.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
43
446
0.96
0.06
3.4
4.1
mmol/l
6.0
8.1
2.23
37
400
(40761536) Microorganisms panel - Urine sediment
13
141
0.92
0.05
3.7
3.6
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
30
287
1.05
0.05
4.2
4.3
mg/mmol
36.5
16.5
0.38
19
195
(40760892) CBC W Ordered Manual Differential panel - Blood
44
426
1.04
0.05
5.7
4.7
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
14
131
1.07
0.03
2.5
2.2
—
17.9
—
0
5
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
137
1381
0.98
0.03
3.7
3.4
mmol/l
5.6
5.6
0.16
124
1277
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
159
1580
1.02
0.02
5.2
4.3
mu/l
2.2
1.9
1.65
144
1476
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
63
620
1.02
0.02
2.0
1.9
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
80
810
0.98
0.02
3.6
3.6
estimate
0.0
0.0
0.00
14
153
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
41
401
1.03
0.02
2.0
1.8
mmol/l
1.3
1.3
0.07
36
356
(40768804) Tissue Pathology biopsy report
53
536
0.99
0.00
2.0
1.9
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
14
141
0.99
0.00
2.6
3.4
%
25.2
20.2
—
5
44
(3012516) Albumin [Mass/volume] in Urine
28
281
1.00
0.00
3.6
3.4
mg/l
124.1
111.8
0.06
19
194
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
148
1479
1.00
0.00
4.1
3.7
mmol/l
2.6
2.8
0.93
139
1383
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
135
1352
1.00
0.00
4.3
3.8
pmol/l
15.4
14.5
3.59
122
1254
(40761535) Cells panel - Urine sediment
10
96
1.04
0.00
3.9
4.5
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
60
595
1.01
0.00
1.6
1.6
g/l
1.9
2.0
0.04
38
338
(3021601) Nitrite [Presence] in Urine by Test strip
81
805
1.01
0.00
5.1
5.0
estimate
0.0
0.0
0.00
16
161
(40768797) Stomach Pathology biopsy report
19
195
0.97
0.00
1.4
1.3
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
24
245
0.98
0.00
1.6
1.8
%
1.5
1.3
0.70
24
221
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
28
278
1.01
0.00
1.2
1.4
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
6
69
0.87
0.00
1.2
1.7
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(4024509)
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
4.4
—
4.0
—
0
5
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
32.3
—
0
7
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
7
0.00
0.00
0.0
2.7
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
5
52
0.96
0.00
1.6
1.4
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040893) Potassium [Moles/volume] in Capillary blood
0
6
0.00
0.00
0.0
2.2
—
4.4
—
0
6
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1002224) Polysomnography panel
7
74
0.94
0.00
1.0
1.1
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
7
0.00
0.00
0.0
2.7
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(4146454)
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
6
62
0.97
0.00
3.2
2.1
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
0
7
0.00
0.00
0.0
1.1
—
116.0
—
0
7
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
7
0.00
0.00
0.0
2.3
—
—
—
0
0
(4133840)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
12.2
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
2.4
—
—
—
0
0
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
42
420
1.00
0.00
3.7
3.7
estimate
0.0
0.0
0.00
15
160
Mortality – FinRegistry
↥Association
Association between endpoint Q17_COMPLEX_CARD_DEFEC and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| Q17_COMPLEX_CARD_DEFEC | 6.375 [4.13, 9.84] | < 0.001 |
| Birth year | 0.996 [0.99, 1.0] | 0.339 |
During the follow-up period (1.1.1998 — 31.12.2019), 91 out of 673 females with Q17_COMPLEX_CARD_DEFEC died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| Q17_COMPLEX_CARD_DEFEC | 6.479 [4.41, 9.53] | < 0.001 |
| Birth year | 0.984 [0.97, 0.99] | 0.001 |
During the follow-up period (1.1.1998 — 31.12.2019), 80 out of 619 males with Q17_COMPLEX_CARD_DEFEC died.
Mortality risk
Mortality risk for people of age
years, who have Q17_COMPLEX_CARD_DEFEC.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.663% | 1.037% |
| 5 | 3.831% | 6.686% |
| 10 | 9.45% | 15.84% |
| 15 | 17.184% | 27.856% |
| 20 | 28.412% | 42.442% |
Relationships between endpoints
↥Index endpoint: Q17_COMPLEX_CARD_DEFEC – Complex cardiac defects
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data